AlphaHelix Molecular Diagnostics AB (publ) reported earnings results for the fourth quarter and full year ended December 31, 2021. For the fourth quarter, the company reported sales was SEK 12.11 million compared to SEK 6.24 million a year ago. Net income was SEK 0.115 million compared to net loss of SEK 0.246 million a year ago.
For the full year, sales was SEK 44.65 million compared to SEK 23.71 million a year ago. Net income was SEK 5.16 million compared to SEK 1.51 million a year ago. Basic earnings per share from continuing operations was SEK 0.08 compared to SEK 0.03 a year ago.